SCHEMBL629908

SCHEMBL629908

COc1ccc(C[C@H](NC(=O)O[C@H]2CCCCN2S(=O)(=O)c2cccc(C(F)(F)F)c2)C(=O)NCCN2CCNCC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ1 P51787 1/20 0.46
HCRTR1 O43613 2/20 0.42
HCRTR2 O43614 2/20 0.42
CTSS P25774 2/20 0.40
CTSL P07711 2/20 0.40
BDKRB1 P46663 6/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
ALDH1A1 P00352 2/20 0.38
POLB P06746 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
REN P00797 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL630006 0.90 KCNQ1 (0.53) KCNQ1HCRTR1HCRTR2CTSSCTSL
SCHEMBL1383175 0.90 KCNQ1 (0.53) KCNQ1HCRTR1HCRTR2CTSSCTSL
SCHEMBL630823 0.85 KCNQ1 (0.49) KCNQ1HCRTR1HCRTR2BDKRB1ALDH1A1
SCHEMBL631050 0.83 KCNQ1 (0.47) KCNQ1HCRTR1HCRTR2BDKRB1ALDH1A1
SCHEMBL630680 0.82 KCNQ1 (0.48) KCNQ1HCRTR1HCRTR2CTSSCTSL
SCHEMBL631034 0.81 KCNQ1 (0.44) KCNQ1HCRTR1HCRTR2BDKRB1POLB
SCHEMBL630055 0.81 KCNQ1 (0.47) KCNQ1HCRTR1HCRTR2CTSSCTSL
SCHEMBL631253 0.77 BDKRB1 (0.42) KCNQ1BDKRB1POLB
SCHEMBL631454 0.76 BDKRB1 (0.45) KCNQ1BDKRB1SMN1; SMN2NPSR1GAA
SCHEMBL630671 0.76 POLB (0.46) KCNQ1HCRTR1HCRTR2BDKRB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778637-B1 FKBP-binding composition and pharmaceutical use thereof AVENTIS PHARMA INC (US) 2012-02-22 EP claimed